A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer

Survival of Korean Adult Cancer Patients by Stage at Diagnosis, 2006-2010: National Cancer Registry Study

(2013) Kyu-Won Jung et al.   Cancer Research and Treatment

EGFR mutations as a predictive marker of cytotoxic chemotherapy

(2012) Jin Hyun Park et al.   LUNG CANCER

Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer

(2012) Seung Tae Kim et al.   Cancer Research and Treatment

Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum

(2011) Jae-Lyun Lee et al.   INVESTIGATIONAL NEW DRUGS

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

(2010) P. A. Kosmidis et al.   ANNALS OF ONCOLOGY

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

(2009) W. T. Lim et al.   ANNALS OF ONCOLOGY

Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer

(2008) Se Hoon Park et al.   LUNG CANCER